Entera Bio to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
The presentation scheduled for Tuesday, February 11th at 12:40-1:10 PM ET in Track 1 will feature a business overview and update by Miranda Toledano, the Company’s Chief Executive Officer.
China's DeepSeek sparks AI market rout
Technology shares around the world slid on Monday as a surge in popularity of a Chinese discount artificial intelligence ...
PancraGEN® Will Continue to be Offered While Interpace Re-evaluates its Previously Announced Re-structuring Plan
Interpace Diagnostics ®, a subsidiary of Interpace Biosciences ®, (“Interpace” or the “Company”) (OTCQX: IDXG) today announced notification that the Centers for Medicare & Medicaid Services (CMS) ...
MU INVESTOR ALERT: Micron Technology, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
January 27, 2025) - The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Micron Technology, Inc. (NASDAQ: MU) common stock between September 28, 2023 and December ...
FDA Approves LEQEMBI® (lecanemab-irmb) IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease
Once every four weeks maintenance dosing may be easier for patients and care partners to continue treatmentAlzheimer's disease progression does ...